Yuval Adar
Director/Board Member chez HBL - HADASIT BIO-HOLDINGS LTD
Profil
Yuval Adar has worked as a Director at Hadasit Medical Research Services & Development Ltd.
since 2014 and at HBL- Hadasit Bio-Holdings Ltd.
since 2021.
Postes actifs de Yuval Adar
| Sociétés | Poste | Début |
|---|---|---|
| HBL - HADASIT BIO-HOLDINGS LTD | Director/Board Member | 19/07/2021 |
Hadasit Medical Research Services & Development Ltd.
 Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Hadasit Medical Research Services & Development Ltd. operates as technology transfer company of Hadassah Medical Center in Jerusalem. It identifies, protects, nurtures and commercializes the discoveries made at Hadassah Medical Center. The company's product include Doxil, Periochip, Travelan, Granagard, and Insupad. The company was founded on December 7, 1986 and is headquartered in Jerusalem, Israel. | Director/Board Member | 09/08/2014 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HBL - HADASIT BIO-HOLDINGS LTD | Finance |
| Entreprise privées | 1 |
|---|---|
Hadasit Medical Research Services & Development Ltd.
Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Hadasit Medical Research Services & Development Ltd. operates as technology transfer company of Hadassah Medical Center in Jerusalem. It identifies, protects, nurtures and commercializes the discoveries made at Hadassah Medical Center. The company's product include Doxil, Periochip, Travelan, Granagard, and Insupad. The company was founded on December 7, 1986 and is headquartered in Jerusalem, Israel. | Commercial Services |
